Agenus focuses on survival data as 0% response rate triggers primary miss
Agenus focuses on survival data as 0% response rate triggers primary miss
Newstafel
Wechsel alle 10-20s FierceBiotech 20. Apr. 2026
Agenus focuses on survival data as 0% response rate triggers primary miss Agenus focuses on survival data as 0% response rate triggers primary miss
FierceBiotech 20. Apr. 2026
Odyssey charts fresh voyage to public markets after abandoning IPO plans last year Odyssey charts fresh voyage to public markets after abandoning IPO plans last year
FierceBiotech 20. Apr. 2026
AstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win AstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win
Medtronic 20. Apr. 2026
Wire-free artery assessment tech joins Medtronic in $585M deal - Stock Titan Wire-free artery assessment tech joins Medtronic in $585M deal - Stock Titan
Medtronic 20. Apr. 2026
Pulnovo completes $100m financing round with Medtronic investment - Yahoo Finance Pulnovo completes $100m financing round with Medtronic investment - Yahoo Finance
Pfizer 20. Apr. 2026
Pfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha Pfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha
Life-Science-Aktien
Kurse + Trend 0 / 49 Live / verfolgt Syncing
Aktuell
Archiv Archiv
Wire-free artery assessment tech joins Medtronic in $585M deal - Stock Titan Pulnovo completes $100m financing round with Medtronic investment - Yahoo Finance Pfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha Medtronic, Pulnovo Join Forces On Pulmonary Denervation After $100M Financing - Citeline News & Insights Pulnovo Medical: $100 Million Raised From Medtronic For Pulmonary Hypertension And Heart Failure Therapies - Pulse 2.0 TD Waterhouse Canada Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat ScreenPoint Medical raises $16m with continued investment from Siemens Healthineers - Medical Device Network Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical - MassDevice